Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pharmacology Research Institute
• Treatments: Vilazodone Hydrochloride

Criteria

Inclusion Criteria:

• Male or female patients 18-65 years of age, inclusive.